QuickView for VCB complex (biogroup)

1. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
2. RAW264.7 macrophages overexpressing Tbc1d23 and/or stimulated with LPS
3. L1000 CMAP - Endometrial adenocarcinoma AN3CA cells treated with small molecule perturbagens
4. Association of miRNAs to clinical response in advanced stage ovarian cancer patients
5. Melanoma miRNA analysis of different tissue sources

1. Elongin C (ELOC/TCEB1)-associated von Hippel-Lindau disease.
2. Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of F…
3. Quantifying the Binding Interaction between the Hypoxia-Inducible Transcription Factor and the von H…
4. The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta.
5. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation.

There were no clinical trials for VCB complex